http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019517510-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-173 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-207 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-207 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 |
filingDate | 2017-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2019517510-A |
titleOfInvention | Phosphoramidate nucleoside derivatives as anticancer agents |
abstract | The present invention relates to derivatives of cladribine of formula (I). The compound is a phosphoramidate derivative in which the phosphoramidate moiety is located at the 3'-hydroxy group of cladribine. The invention also relates to pharmaceutical compositions of cladribine derivatives and their use in therapy. The compounds are useful for the treatment of cancer. [Chemical formula 1] |
priorityDate | 2016-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 804.